Overview

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Subjects who completed ZA-003 were eligible to receive an additional year of treatment in this extension study.
Phase:
Phase 3
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Sodium Citrate
Zuclomiphene